Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Long-Term Debt Repayments (2021 - 2022)

Treace Medical Concepts' Long-Term Debt Repayments history spans 2 years, with the latest figure at -$33.9 million for Q4 2022.

  • For Q4 2022, Long-Term Debt Repayments changed N/A year-over-year to -$33.9 million; the TTM value through Dec 2023 reached -$33.9 million, changed N/A, while the annual FY2021 figure was $1.8 million, N/A changed from the prior year.
  • Long-Term Debt Repayments reached -$33.9 million in Q4 2022 per TMCI's latest filing, down from $33.9 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $33.9 million in Q2 2022 to a low of -$33.9 million in Q4 2022.